Cardiac troponin I as an early prognosis biomarker after trauma: a retrospective cohort study

Abstract

BackgroundThe significance of cardiac troponin I (cTnI) elevation after trauma is debated. We therefore explored the association between cTnI elevation at admission after trauma and ICU mortality. MethodsWe performed a retrospective analysis from a prospectively constituted database, of patients admitted to ICU after trauma at a single centre, over a 36 month period. According to cTnI plasma concentration at admission, patients were categorised into three groups: normal (<0.05 ng ml−1), intermediate (0.05–0.99 ng ml−1), or high concentration (≥1.0 ng ml−1). Associations of pre-hospital conditions or cTnI elevation and mortality were analysed by multivariate logistic regression. ResultsAmong the 994 patients, 177 (18%) had cTnI elevation at ICU admission. Of this total, 114 (11%) patients died in the ICU. The cTnI release was an independent predictor of ICU mortality with a concentration–response relationship [odds ratio (OR) 4.90 (2.19–11.16) and 14.83 (4.68–49.90) for intermediate and high concentrations, respectively] and Day 2 mortality [OR 2.23 (1.18–5.80) and 7.49 (2.77–20.12) for intermediate and high concentrations, respectively]. The severity of thoracic trauma [OR 2.25 (1.07–4.55) and 3.23 (2.00–5.27) for Abbreviated Injury Scale scores 1–2 and ≥3, respectively], out-of-hospital maximal heart rate ≥120 beats min−1 [OR 2.22 (1.32–3.69)], and out-of-hospital shock [OR 2.02 (1.20–3.38)] were independently associated with cTnI elevation. ConclusionsRelease of cTnI was an independent predictor of ICU mortality, suggesting that this biomarker can be used in daily practice for early stratification of the risk of ICU death. Thoracic trauma was strongly associated with cTnI elevation.